Susanne Picard, the founder and president of SPharm, has been selected as one of the speakers at this year’s Canada Talks Pharma conference being held this May 15-16, 2018 in Toronto.

Susanne is a highly regarded expert and speaker trusted for over 26 years to provide insight into Drug Development activities. She will be presenting on the topic of “Overcoming obstacles in the drug approval process in Canada.”

Canada Talks Pharma is a fast growing conference series about clinical research and global clinical trials. In addition to industry leading speakers, the conference is also excited to be presenting the keynote speaker of this year’s event TED Senior Fellow and TED Speaker, award winning scientist, professor, entrepreneur, and CSO of Spiderwort, Dr. Andrew Pelling. Andrew has built a career on unapologetic curiosity. His research lab brings together scientists, engineers and artists to explore speculative living technologies of the future with low-cost materials and methods. If creating body parts made from plants or growing living skins on LEGOs peaks your curiosity, then you are encouraged to not miss Andrew Pelling’s keynote at this year’s Canada Talks Pharma event.


With over 20 years of consistent and successful results, SPharm has become one of the leading Drug Regulatory Advisory firms in Canada. Drug companies from around the world count on SPharm to help them navigate the drug (and other health products) review & approval process in Canada.

Après plus de 20 ans de résultats et de succès constants, SPharm est devenue une entreprise de services de référence au Canada en stratégie de développement de médicaments et affaires réglementaires. Des compagnies pharmaceutiques à travers le monde comptent sur SPharm pour faciliter le processus d’homologation de leurs médicaments (et autres produits de santé) au Canada.